JATT Acquisition Corp. (NYSE: JATT)
JATT Acquisition Corp. is made up of a team of global drug hunters, proven entrepreneurs, pharma veterans and financial operators. With several decades of combined experience and successful multi-billion dollar deals, we have honed our formula to unlock future value powered by deep sector and capital markets knowledge.
The Team
Dr. Someit Sidhu - Founder, CEO & Director
Co-Founder and CEO of Izana Bioscience & Akaza, Co-Founder of Pathios Therapeutics
Verender S. Badial - CFO
Former MD in ECM at Société Générale and ABN AMRO Rothschild
Founder of Cryfield Investments
Arnout Ploos van Amstel - Director
Co-Founder of MoonLake Immunotherapeutics and Former Head of Global Business Unit Immunology, Hepatalogy and Dermatology at Novartis
Tauhid Ali ,PhD - COO & Director
Former EVP at Cambrian Biopharma and Head of Rare Disease Strategy & Founder of TAKcelerator™ at Takeda
Graeme Sloan - General Counsel
Former Global Co-Head of M&A; at Morrison & Foerster LLP, former global Co-Chair of M&A; at Latham & Watkins LLP, Co-Chair of Lex Mundi cross border transaction group
Javier Cote‐Sierra, PhD - Director
Co-Founder & CSO of Allianthera Biopharma and Former Head of Inflammation & Immunology External Innovation at Sanofi Genzyme
Yuan-Hua Ding, PhD - Advisor
Co-Founder & CEO of Allianthera Biopharma and Co-CEO at the BayRay Innovation Center, former Head of Pfizer Asia Discovery Labs